Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

Clinical trial NCT04810585 · UNKNOWN

Trial details

NCT number: NCT04810585
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Recurrent or Metastatic Colorectal Cancer

Start date: 2020-04-20
Primary completion: 2025-10-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.